Publications by authors named "Sivgin S"

Article Synopsis
  • The study aimed to gather data on paroxysmal nocturnal hemoglobinuria (PNH) patients from hematology centers across Turkey to understand their clinical features and management.
  • A retrospective analysis was conducted on 60 PNH patients' medical records, revealing key demographics, symptoms, treatment responses, and survival outcomes.
  • The research found that fatigue and abdominal pain were the most common symptoms, and most patients transitioned to eculizumab treatment, with a median survival of 42 months, making this the first comprehensive review of PNH cases in Turkey.
View Article and Find Full Text PDF

Objective: Chronic antigenic stimulation is frequently blamed in the pathogenesis of extranodal marginal zone lymphomas including splenic marginal zone lymphoma (SMZL). Chronic hepatitis C is frequently observed in SMZL patients in some geographical regions. However, these reports are largely from North America and Europe, and data from other countries are insufficient.

View Article and Find Full Text PDF
Article Synopsis
  • The RESPONSE-2 study is a phase 3 trial comparing ruxolitinib to the best available therapy (BAT) for patients with polycythemia vera (PV) who are resistant or intolerant to hydroxyurea.
  • At the analysis point, 93% of ruxolitinib patients remained on the treatment, with 78% maintaining hematocrit control, while 24% achieved durable complete hematologic remission (CHR) compared to just 3% in the BAT group.
  • The results support the use of ruxolitinib as a standard treatment option for this specific patient population.
View Article and Find Full Text PDF

Aim: The aim of this study is to determine the immunohistochemical properties of Ki-67, P53 expression and loss of P16, and to assess their relationship with both clinical parameters and patient survival in DLBCL.

Method: Forty patients, diagnosed at the Pathology Department of our institute with nodal DLBCL were selected as the study group. The relationship between P16, P53, Ki-67 expressions and clinical and laboratory parameters like age, gender, performance status, Eastern Cooperative Oncology Group (ECOG), clinical stage, presence of B-symptoms, bone marrow involvement, International Prognostic Index (IPI) score, lactate dehydrogenase (LDH) level, extranodal extension, relapse, C-reactive protein (CRP), sedimentation, number of leukocytes in patients and patient survival were then statistically evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • Ruxolitinib, a JAK1 and JAK2 inhibitor, was found more effective than best available therapy for controlling hematocrit and improving symptoms in polycythemia vera patients with splenomegaly who were ineffective on hydroxyurea.
  • The RESPONSE-2 study researched ruxolitinib’s efficacy and safety in patients without splenomegaly who required second-line treatment, involving 48 hospitals across 12 countries.
  • The primary goal was to measure the percentage of patients achieving hematocrit control by week 28, with results from 74 patients on ruxolitinib and 75 on standard therapy being analyzed.
View Article and Find Full Text PDF
Article Synopsis
  • Iron overload is a major concern for leukemia patients and those who have had allogeneic hematopoietic stem cell transplantation (alloHSCT), impacting survival rates.
  • Researchers analyzed the bone marrow iron scores (BMIS) of 125 patients to understand pre-transplant iron levels and their effects.
  • Results showed that higher BMIS was linked to poorer overall survival and disease-free survival, suggesting BMIS can be used for risk assessment in alloHSCT patients.
View Article and Find Full Text PDF

Introduction: The use of αβ+ T-cell-depleted grafts is a novel approach to prevent graft failure, graft-versus-host disease (GVHD), and non-relapse mortality (NRM) in patients undergoing haploidentical hematopoietic stem cell transplantation.

Patient And Method: Thirty-four patients with acute leukemia and lacking a match donor were treated with αβ T-cell-depleted allografts from haploidentical family donors. A total of 24 patients had acute myeloid leukemia (AML) and 10 had acute lymphoblastic leukemia.

View Article and Find Full Text PDF

Introduction: Hematopoietic stem cell transplantation is a common and preferred treatment of lymphomas in many centers. Our goal was to determine the association between pretransplant iron overload and survival in patients who underwent autologous hematopoietic stem cell transplantation (autoHSCT).

Patients And Methods: A total of 165 patients with lymphoma, who underwent autoHSCT between the years of 2007 and 2014, were included in this study.

View Article and Find Full Text PDF

Aim: Iron overload results in increased infection, venous-oclusive disease and hepatic dysfunction in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients. Liver is one of the most common sites of iron overload.

Patients And Methods: A total of 50 alloHSCT recipients that underwent liver biopsy in Erciyes Stem Cell Transplantation Hospital, Erciyes University, between 2004 and 2011 were enrolled in the study.

View Article and Find Full Text PDF

Purpose: Relapse of leukemia relapsing after allogeneic (allo) stem cell transplantation (SCT) remains an important problem. Cytoreductive chemotherapy followed by donor leukocyte infusion (DLI) is one of the treatment modalities in relapsed patients. The current study evaluated the factors affecting overall survival (OS) in allo-SCT patients who received DLI after the first relapse.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the effectiveness of three G-CSF agents (Neupogen®, Leucostim®, and Granocyte®) in mobilizing CD34(+) cells from donors who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).
  • - An analysis of 243 donors revealed no significant differences in the total collected PB CD34(+) cell counts among the three G-CSF groups, despite variations in median doses administered.
  • - The findings concluded that the biosimilar Leucostim® is as effective as the original Neupogen® and Granocyte® for mobilizing stem cells in prospective donors.
View Article and Find Full Text PDF

A 42-year-old male patient was admitted to our hospital for planning autologous hematopoietic stem cell transplantation (auto-HSCT). He was diagnosed as multiple mycloma (IgG type Kappa) in 2003. His physical examination was normal with no important abnormality on laboratory evaluation.

View Article and Find Full Text PDF

The aim of the present study was to define the possible association between blood parameters and hair iron concentration in patient groups showing a difference in body iron content. The study population comprised subjects with iron deficiency anaemia and transfusion-related anaemia with different body iron contents and a healthy control group. All the cases included in the study were examined with respect to hair iron concentration, serum iron, total iron-binding capacity (TIBC), transferrin saturation and erythrocyte markers in the total blood count with ferritin values.

View Article and Find Full Text PDF

Background/aims: The aim of this study was to assess the association between red cell distribution width and inflammation in biopsy proven non-alcoholic steatohepatitis.

Methodology: Fifty four subjects with non-alcoholic steatohepatitis and thirty nine controls were enrolled for the study. Liver biopsy specimens were scored by using non-alcoholic fatty liver disease activity score by a single experienced liver pathologist.

View Article and Find Full Text PDF

In this multicenter retrospective analysis, we aimed to present clinical, laboratory and treatment results of 94 patients with Hairy cell leukemia diagnosed in 13 centers between 1990 and 2014. Sixty-six of the patients were males and 28 were females, with a median age of 55. Splenomegaly was present in 93.

View Article and Find Full Text PDF

Familial Mediterranean fever (FMF) is a genetic disease with autosomal inheritance characterized by recurrent fever, abdominal pain, and serositis attacks. It is relatively common in the races and ethnical groups around Mediterranean Sea (Sephardic Jews, Armenians, Turks and Arabians). Hereditary elliptocytosis (HE) is common genetic defect of the red blood cell membrane skeleton.

View Article and Find Full Text PDF

Ataxia-telangiectasia (AT) is a rare multisystem, neurodegenerative genetic disorder. Patients should be closely monitored due to risk of malignancy development. Due to its wide clinical heterogeneity, it often leads physicians to an inaccurate or missed diagnosis, and insight into this rare disease is important.

View Article and Find Full Text PDF

Blood component donations by apheresis have become more common in modern blood transfusion practices. We compared three apheresis instruments (Fenwal Amicus, Fresenius COM.TEC, and Trima Accel) with regard to platelet (PLT) yield, collection efficiency (CE), and collection rate (CR).

View Article and Find Full Text PDF

Background: A variety of apheresis instruments are now available on the market for double dose plateletpheresis. We compared three apheresis devices (Fenwal Amicus, Fresenius COM.TEC and Trima Accel) with regard to processing time, platelet (PLT) yield, collection efficiency (CE) and collection rate (CR).

View Article and Find Full Text PDF

Introduction: We aimed to determine the frequency and microbiological causes of diarrhea occurring during the first 100 days in allogeneic (allo-) and autologous (auto-) stem cell transplantation (SCT) patients.

Methodology: A total of 452 patients who underwent transplantation due to hematological or solid organ malignancy were included. From the administration of the conditioning regimen up to day 100 post-transplant, diarrhea cases lasting at least three days with a minimum of three episodes per day were evaluated.

View Article and Find Full Text PDF

Bone metastases are frequently observed in patients with certain types of cancer and are significant cause of morbidity. Zoledronic acid (ZA) is routinely prescribed for patients with bone metastases by affecting osteoclast function. We aimed to assess the effect of ZA over time in patients with bone metastases by analyzing novel bone turnover marker levels including receptor activator of nuclear factor-k B ligand (RANKL) and osteoprotegerin (OPG) in serum and gingival crevicular fluid (GCF).

View Article and Find Full Text PDF

Unlabelled: A 50-year-old male patient previously diagnosed with acute myelomonocytic (M4) leukemia in July 2009 underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). During the pre-transplant period complete blood count (CBC), liver and renal function tests, coagulation tests, and other parameters were normal. On the first day of transplantation teicoplanin (400 mg d-1 for the first 3 d, and then 400 mg d-1) and caspofungin (first dose was 1×70 mg d-1, followed by 1×50 mg d-1) were started intravenously due to white plaques and oropharyngeal candidiasis in the patient's mouth and perianal erythema.

View Article and Find Full Text PDF

Background: Granulocyte-colony stimulating factor (G-CSF) is widely administered to donors who provide peripheral blood stem cells (PBSCs) for individuals who undergo hematopoietic stem cell transplants. G-CSF administration is associated with a small but definite risks of serious adverse events like splenic rupture.

Case Study: In this case, we report a 40 year old women, a healthy donor for her sister who has aplastic anemia, who had sharp left upper abdominal pain on the forth mobilization day.

View Article and Find Full Text PDF

Langerhans cell sarcoma, a tumour with markedly malignant cytological features that originates from Langerhans cells, is a very rare disease. We report the first case of 39-year-old male with Langerhans cell sarcoma arising in the nasopharynx. We chose the 2-chlorodeoxyadenosine (2-CDA) regimen as first-line chemotherapy, and clinical improvement of Langerhans cell sarcoma was obtained.

View Article and Find Full Text PDF

Objective: Serum albumin level is considered to be a marker reflecting the nutritional status in both healthy subjects and patients with malignancies. In this study we sought to investigate the association between pretransplantation serum albumin levels and prognosis among patients with leukemia who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).

Methods: We retrospectively analyzed the data of 102 patients who underwent alloHSCT from 2004 to 2010.

View Article and Find Full Text PDF